Similarly, in-vitro administration of ghrelin did not significantly change viability, proliferation, apoptosis, and cellular respiration in HLC-1 lung adenocarcinoma cell line (non-endocrine) (99). This evidence concerns the gene GHRL and lung adenocarcinoma.